Untitled attachment

Notices where this attachment appears

1. Embed this notice
   Minoru Saba (minorusaba@toad.social)'s status on Thursday, 26-Dec-2024 21:36:11 JST Minoru Saba

   in reply to

   @murodegrizeco
   Meiji Seika Pharma obtained exclusive rights from CSL Seqirus (Australian biotech co.) to distribute #replicon vaccine in #Japan with approval from ultra-cautious Ministry of Health, Labor & Welfare, but had to deal with misinformation re the new technology & is seeking damages from Rep. Kazuhiro Haraguchi for "repeated defamatory remarks"
   https://www.asahi.com/ajw/articles/15566602

   Haraguchi's Japanese Wikipedia bio shows a complex career but not when he became antivax
   https://ja.wikipedia.org/wiki/%E5%8E%9F%E5%8F%A3%E4%B8%80%E5%8D%9A